These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 3183496

  • 1. Standard assays underestimate the concentration of heparin in neonatal plasma.
    Schmidt B, Mitchell L, Ofosu F, Andrew M.
    J Lab Clin Med; 1988 Nov; 112(5):641-3. PubMed ID: 3183496
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anticoagulant effects of heparin in neonatal plasma.
    Schmidt B, Ofosu FA, Mitchell L, Brooker LA, Andrew M.
    Pediatr Res; 1989 Apr; 25(4):405-8. PubMed ID: 2726317
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma.
    Schmidt B, Mitchell L, Ofosu FA, Andrew M.
    Thromb Haemost; 1989 Dec 29; 62(4):1074-7. PubMed ID: 2482548
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A method of determining heparin in blood plasma based on its antithrombin activity].
    Taktashev RE, Suvorova AV, Miller VE, Kolesnikova OI.
    Lab Delo; 1990 Dec 29; (12):59-61. PubMed ID: 1710698
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspective.
    Favaloro EJ, Bonar R, Aboud M, Low J, Sioufi J, Wheeler M, Lloyd J, Street A, Marsden K, RCPA QAP in Haematology.
    Lab Hematol; 2005 Dec 29; 11(3):157-62. PubMed ID: 16174600
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L, Dewar L, Song Y, Kulczycky M, Blajchman MA, Fenton JW, Andrew M, Delorme M, Ginsberg J, Preissner KT.
    Thromb Haemost; 1995 Mar 29; 73(3):405-12. PubMed ID: 7545318
    [Abstract] [Full Text] [Related]

  • 19. Refinement and feasibility testing of a manual micro-method for protamine titration.
    Newall F, Johnston L, Ignjatovic V, Summerhayes R, Monagle P.
    Int J Lab Hematol; 2009 Aug 29; 31(4):457-61. PubMed ID: 18371057
    [Abstract] [Full Text] [Related]

  • 20. Effect of continuous low-dose intravenous heparin administered during operation on postoperative measurements of antithrombin III and antifactor Xa.
    Jennings SA, Heather BP, Greenhalgh RM.
    Surgery; 1984 Sep 29; 96(3):550-5. PubMed ID: 6474360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.